Hongtai Xiong

ORCID: 0009-0005-6260-1877
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoplatforms for cancer theranostics
  • Immunotherapy and Immune Responses
  • Management of metastatic bone disease
  • Cancer Treatment and Pharmacology
  • Pain Mechanisms and Treatments
  • Transcranial Magnetic Stimulation Studies
  • Phagocytosis and Immune Regulation
  • Polysaccharides and Plant Cell Walls
  • Immune Cell Function and Interaction
  • Pain Management and Treatment
  • Nanoparticle-Based Drug Delivery
  • Colorectal Cancer Treatments and Studies
  • Graphene and Nanomaterials Applications

Chinese Academy of Medical Sciences & Peking Union Medical College
2023-2025

Guang’anmen Hospital
2023-2025

Background: Colorectal cancer (CRC) is a leading cause of cancer-related deaths, with over 1.9 million new cases and 904,000 deaths in 2022. Chemotherapy primary treatment for CRC but often leads to myelosuppression, significantly affecting efficacy patient outcomes. Predictive tools chemotherapy-induced myelosuppression are currently lacking. Methods: This retrospective study analyzed 855 patients from Guang'anmen Hospital who received first-line chemotherapy (CapeOx, FOLFOX, FOLFIRI)...

10.7150/jca.104412 article EN cc-by-nc Journal of Cancer 2025-01-20
Coming Soon ...